Skip to main content
MapleLMS Implementation
Conferences and Meetings 201. Granulocytes, Monocytes, and Macrophages: Poster III

201. Granulocytes, Monocytes, and Macrophages: Poster III

Short name: 201. Granulocytes, Monocytes, and Macrophages: Poster III
Course start date: 11/09/2025

Sections

General
0 activities

Deciphering Genotype-Phenotype Correlations and the Mechanism of the Action of Neutrophil Elastase Inhibitors during ELANE Associated Neutropenia Utilizing Molecular Modeling Software
Evaluating Treatment-Related Outcomes in the Era of Targeted Therapy for Rosai Dorman and Erdheim Chester Disease
High Prevalence of Concomitant Autoimmunity in Patients with Rosai-Dorfman Disease
Low-Frequency Mosaicism of the BRAF Mutation As the Origin of Langerhans Cell Histiocytosis
Pathological Subtyping, Outcomes, and Survival Trends of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Multicenter Analysis of 464 Patients
Patients (pts) with Optimized Hemophagocytic Lymphohistiocytosis (HLH) Inflammatory (OHI) Index-Confirmed Diagnosis of Malignancy-Associated HLH (mHLH) and Emapalumab Treatment
Prognostic Value of BRAFV600E in Peripheral Blood of Children with Langerhans Cell Histiocytosis: A Multicenter Project of the European Consortium for Histiocytosis
Self-Supervised Learning Model Accurately Diagnoses Hemophagocytic Lymphohistiocytosis from Histology Images
Treatment Strategies and Outcomes of the Rare Histiocytic Disorders: Long-Term Results of the International Rare Histiocytic Disorders Registry (IRHDR)